ABC News’ speaks with law professor Anya Prince on how 23andMe’s recent layoffs and shuttering of its drug development arm ...
Concerns about 23andMe's business prospects is raising questions about the genetic testing company's customer data.
( NewsNation) — Genetic testing company 23andMe has faced a series of struggles this year, culminating in end-of-year mass ...
The financial struggles of genetic testing and ancestry company 23andMe are raising questions about the security of customers ...
Me is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...
NEW YORK — 23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics ...
The company said it is evaluating strategic alternatives, including licensing agreements and asset sales, for its therapies ...
The DNA-testing firm said in a Tuesday SEC filing, “there is substantial doubt about the company’s ability to continue.” ...
The future of 23andMe, a genetic testing company, is uncertain due to financial challenges and recent workforce reductions.
In the year since its hack, 23andMe has lost all of its value and most of its governing board — and somehow, things just keep ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback